Securities code: Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) securities abbreviation: Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) Announcement No.: 2022012
Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513)
Announcement on the forecast of daily connected transactions in 2022
The board of directors and all directors of the company guarantee that there are no false records and misleading statements in the contents of this announcement
Or major omissions, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Important content tips:
This connected transaction belongs to the decision-making authority of the board of directors of the company and does not need to be submitted to the general meeting of shareholders for deliberation.
This connected transaction is a reasonable estimate based on the needs of the company’s normal production and business activities,
It is an important means for the company to make rational use of resources. The pricing policy strictly follows the principle of openness, fairness, impartiality and equivalence
The general business principle of compensation is conducive to the development of relevant businesses of the company and will not affect the company’s sustainable operation ability and profitability
The profitability and asset independence have an adverse impact, and there is no case of great dependence on related parties.
1、 Basic information of daily connected transactions
(I) review procedures for the performance of daily connected transactions
Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) (hereinafter referred to as “the company”) was called on March 28, 2022
The second meeting of the third board of directors and the second meeting of the third board of supervisors deliberated and adopted the
In 2022, Ms. Wang Ying, a related director, avoided the proposal
After voting, the independent directors of the company approved the related party transaction in advance and expressed their independent opinions.
This proposal belongs to the decision-making authority of the board of directors of the company and does not need to be submitted to the general meeting of shareholders of the company for deliberation.
(II) estimated amount and category of daily connected transactions
Unit: 10000 yuan
The reason for the large difference between the business ratio of the estimated amount of related party transactions in the same category and the amount of related party transactions in the previous year from the beginning of the current year to the disclosure date and the transaction amount (%) generated by the difference between the accumulated amount of related party transactions and the actual amount of related party transactions in the current year (%)
The labor construction project provided by the related party Sichuan taihe’an according to the actual production and operation needs 850.00 2.94 15.41143065 4.45
Limited company
Total 850.00 15.41143065
(III) prediction and implementation of previous daily connected transactions
On April 16, 2020, the company held the 9th meeting of the second board of directors, deliberated and approved the proposal on reviewing the fire engineering construction project and related party transactions of the wholly-owned subsidiary Chengdu shuode Pharmaceutical Co., Ltd., and agreed that the wholly-owned subsidiary Chengdu shuode Pharmaceutical Co., Ltd. signed the fire engineering construction contract with the related party Sichuan taihe’an Construction Engineering Co., Ltd. according to the needs of project construction, with the contract amount of 22.5 million yuan, From the signing of the contract to the disclosure date of this announcement, the company has accumulated RMB 219625 million with Sichuan taihe’an Construction Engineering Co., Ltd. After the listing of the company and before this forecast, there has been no daily forecast of related party transactions.
2、 Basic information and relationship of related parties
(I) basic information of related parties
1. Company name: Sichuan taihe’an Construction Engineering Co., Ltd
2. Unified social credit Code: 9151 China International Marine Containers (Group) Co.Ltd(000039) 9764765g
3. Legal representative: Yu MINMING
4. Company type: limited liability company
5. Registered capital: 10 million yuan
6. Date of establishment: October 23, 2014
7. Registered address: No. 30, floor 2, building 5, No. 6, Wuqing South Road, Wuhou District, Chengdu
8. Major shareholders: Wang Kun holds 52% and Yu MINMING holds 48%
9. Business scope: Construction Engineering; Highway engineering; Water conservancy and hydropower projects; Fire fighting facilities engineering; Power engineering; Environmental protection engineering; Steel structure works; Municipal utilities; Landscaping works; Urban and road lighting works; Building electromechanical installation works; Electromechanical engineering; Communication engineering; Electronic and intelligent engineering; River and lake regulation works; Engineering design; Fire technical services; Mechanical equipment leasing; Sales of building materials.
10. Financial status of the last year: unable to obtain due to the confidentiality of the other party’s financial data.
(II) relationship with listed companies
The company is a company in which Wang Kun, the brother of Wang Ying, the controlling shareholder, actual controller and chairman, holds 52% of the shares and serves as a supervisor.
(III) performance capability analysis
Related parties exist in accordance with the law and operate normally. The previous similar related party transactions are well executed, have sufficient performance capacity and can strictly abide by the contract.
3、 Main contents of daily related party transactions
(I) signing of related party transaction agreement
This connected transaction is expected to be conducted in 2022, and relevant agreements have not been signed. After being deliberated and approved by the board of directors of the company, the company (and its subsidiaries) will sign specific transaction contracts or agreements with related parties according to the business development.
(II) pricing principle of related party transactions
The related party transactions of the company shall be conducted in accordance with the principles of voluntariness, equality, mutual benefit, fairness and fairness. The main content of this transaction between the company and related parties is to accept the labor services provided by related parties. The transaction price will be implemented according to the market fair price. When there is no clear market price and government guidance price for the traded goods or services, the transaction price shall be determined by both parties through negotiation, and relevant related transaction agreements shall be signed to clarify the related transaction price. 4、 Purpose of daily connected transactions and its impact on Listed Companies
This connected transaction is necessary for the company’s normal production and business activities and an important means for the company to make rational use of resources. The pricing policies of various daily connected transactions strictly follow the general commercial principles of openness, fairness, impartiality and compensation for equal value, which is conducive to the development of relevant businesses of the company, and will not have an adverse impact on the company’s sustainable operation ability, profitability and asset independence. There is no greater dependence on connected persons, and there is no damage to the interests of the company and shareholders, especially small and medium-sized shareholders.
5、 Online announcement attachment
(I) resolutions of the second meeting of the third board of directors of the company;
(II) resolutions of the second meeting of the third board of supervisors of the company;
(III) prior approval opinions and independent opinions of independent directors of the company on matters related to the second meeting of the third board of directors.
It is hereby announced.
Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513)
Board of directors
March 29, 2022
